Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - NAVIDEA BIOPHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_10k.htm |
| EX-3.1 - EXHIBIT 3.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex3-1.htm |
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex32-1.htm |
| EX-10.5 - EXHIBIT 10.5 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex10-5.htm |
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex21-1.htm |
| EX-32.2 - EXHIBIT 32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex32-2.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex24-1.htm |
| EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex31-2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Navidea Biopharmaceuticals, Inc.
Dublin, Ohio
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-05143, 333-119219, 333-130636, 333-130640, 333-153110, and 333-158323) and on Form S-3 (Nos. 333-156810, 333-168485 and 333-173752) of Navidea Biopharmaceuticals, Inc. of our reports dated March 6, 2012, relating to the consolidated financial statements and the effectiveness of Navidea Biopharmaceuticals, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
Chicago, Illinois
March 6, 2012